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E. Hatziagor ou 1, A. Vidalis 2, M. Quittan ~, O. Schulffrid ~, B. Bandtu a, J. Tsanakas 1 
and the DISABKIDS Group 
~Pediatric PuImonology Unit, Aristotle University of 77~essaIoniki, H ppokratio 
General Hospital, Greece, 2 Psychiatric Unit,Hippokratio General Hospital, 
Greece, s Department of Physical Medicine arm Rehabilitation, University of 
V~enna, Austria 
Background:  Ojs~tic fibrosis (CF) is the most common inherited isease. Despite 
improvement ha survival, the disease is progressive, especially with respect o the 
decline in pulmonary function a d growth, which in turn may have an impact on a 
patient's quality of l ife (QoL). A im:  The DISABKIDS inslruments have been 
lranslated and adapted for use in several languages to assess health related quality 
of l ife in chi ldren and adolescents with CF, the benefits of treatment and to give 
parents and chi ldren a voice in health care. Pat ients  and  methods:  The 
D ISABI~DS instruments are available as sell" or proxy report forms and include 
the DISABKIDS Chronic Generic Measure (DCGM 37), the DISABKIDS Smiley 
Measure and the Oystic Fibrosis specific module. The 37 items of the DCGM 
comprise 6 sub scales: independence, motion, social inclusion, social exclusion, 
physical l imitation and medication. The CF module consists of 10 items (impact mad 
treatment). 43 children and adolescents aged 8 16 years old and 34 parents 
participated in DISABI~DS'  field study. Results: Cr onbach's alpha as a measure of 
internal consistency reached satisfactory values ranging from c{ 0.71 to c{ ~),93 
for the sub scales of the DCGM 37 mad the CF module. The DCGM 37 
discriminates wel l  between different cbronic conditions (cystic fibrosis asthma, 
juveni le artbritis, atopic dermatitis, diabetes, cerebral palsy, epilepsy). Both the 
DCGM 37 and the CF module distinguish between different levels of severity, 
assessed by cl inician's severity assessment measures. Condus ions :  The 
D ISABI~DS instruments are a valid measure of QOL of patients with CF that 
differentiate for severity and illness. Comparison between countries can be made, as 
they are available in several languages. They give new data, as caregiver and patient 
perceptions of CF Quality of Life can be stimated. 
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A.L. Quittner and coi l  
R. Nobil i  1, C. Br aggion 2, C. Colonlbo 1, D. Fazio 3, M.P. Inter mite 4, N. Opr andi 5, M. 
Panett a6, R. Pescini 7, S. Spina 6, G. Apolone 8
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~Istituto Mario Negri, Milano - Italy 
Aims:  To compare quality of l ife (QOL) of CF people l iving in unl ike areas and 
countries, different language versions of the same inslrument are useful. So Ital ian 
CF Society decided to lranslate ha Italian mad validate CFQR,  the most widespread 
questiommire to assess QOL ha CE 
Methods:  MAPI  prceedure was used. It includes 6 steps:2 lr anslations in Italian, i a 
reconciled version, back lranslation, 2~ reconciled, cognit ive debriefing, proper 
validation. Validation involved a multicenter team of researchers coming from north 
to south of Italy in order to make the validation sample as much representative as 
possible of all Country. 
Results: The major difficulty is harmonizing the items across Engl ish and Italian, 
considering that CFQR includes 4 versions for 6 11 children, 12 13 children, 
caregiver/parent and 14+ patients. Very helpful comments are obtained from parents 
and patients taking part in cognit ive debriefing. The main concerns of researchers 
are about ratings suggested to be changed to frequencies (always to never) and the 
difficulties of 6 years old children to understand pbr asal expressions, perfectly clear 
for elder children, and t iming reference. Cognitive debriefing included 20 subjects 
in all whi le  proper validation includes 2CO subjects in all. This step is ongoing mad 
it wi l l  end ha Apri l  2CO5. Considering how CF patients' cl inical condition can 
change fol lowing therapy, for questionnaire validation Cr onbach c{ test seems more 
suitable than test retest prceedure. Questionnaire data wi l l  be compared with 
cl inical ones collected by means of a form developed on purpose. 
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comparison between parent and child perception of QOL 
E. Hatziagorou 1, A. Vidalis 2, I. Loukou ~, S. Doudounakis ~, J. Tsanakas I and the 
DISABKIDS Group 
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Background:  Considerable progress has been made over the past two decades in 
defining and measuring Health Related Quality of Life (QQL). There is increasing 
evidence that these measures provide objective information on the impact of a 
cbronic illness and it's treatment on a patient's daily activities mad life. A im:  To 
assess the QOL in children with Oystic Fibrosis (CF) and to make comparisons 
between patients and their parents on the effect of CF on their QOL. Pat ients mid 
methods:  Thirty six children with CF and their parents used the wel l  validated 
D ISABI~DS Questionnaire (including a cbronic generic and a disease specific 
questionnaire for CF). The chi ldren group, aged 8 16 years, comprised of all grades 
of disease severity, assessed by clinician's everity assessment measures. ResuRs: 
Parents achieved lower s~ores on emotion, physical l imitation and treatment sub 
scales, whi le  they achieved higher scores on independence mad social inclusion 
scales (p<0.05). Conclusion: Parents underestimated some aspects of their children 
QOL. The relationship between caregiver and patient perceptions of CF Quality of 
L i fe should be taken under consideration i order to monitor CF control adequately. 
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ValidaEon of the Turkish version of the Cystic Fibrosis Quality of Life 
QuesEonnaire (CFQoL): Pilot Study 
O. Cobma 1, D. Sindel 2, A.R. Ozdincler 1, I. Yeldan 1, C. Incesu 1 
llstanbuI University, School of Physical Therapy arm Rehabilitation, 21stanbuI 
University, IstanbuI Faculty of Medicine, Department of Physical Medicine and 
Rehabilitation 
Aims:  The purpose of this study was to validate the Oystic Fibrosis Questionnaire 
(CFQ R Child version Quiemer, Sweeny et al.) in Turkey. This questiomlaire is a 
disease specific measure of health Related Quality of Life for children with Oys~ic 
Fibrosis (CF). 
Methods:  The Cystic Fibrosis Questiomlaire (CFQR Child version Quittner, 
Sweeny et al.) was translated into Turkish by a qualif ied translator. A backward 
translation was completed by a native speaker tmaware of the intent and concepts 
of the questionnaire. A third expert compared the original Engl ish list to backward 
translated Engl ish list. A~er discussion between translators, a consensus forward 
translation was produced. Consensus forward lranslation was administered to 30 
children, ranging in age from 7 to 13 years. 
Results:  Scale level analyses indicated good intemal consistency ccefficent s for all 
scales on the CFQ child (Cronbach's 0: 0.600.70),  with the exceptions of 
Emotional State (Cronbach's 0:~).50) and Social (Cronbach's 0: 0.54). Wilcoxon 
Signed Ranks Test indicated that test and retest results (10 14 days) had no 
statistically significant differencies (p>O.05), and cortfirmed a good external 
reliability.Mama Whilney Test results indicated agreement between males mad 
females. 
Finally, pearson correlations didn't indicate any associations between CFQ Child 
scores and child's age. 
Conclusion: This pilot study the Turkish CFQ Child version showed good internal 
and extemal validity. After this pilot study administered different health level mad 
wide range of population, it wi l l  be useful for studies. 
